These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21377001)

  • 1. Editorial comment. Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer.
    Jones JS
    Urology; 2011 Mar; 77(3):552. PubMed ID: 21377001
    [No Abstract]   [Full Text] [Related]  

  • 2. Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer.
    Resnick MJ; Lee DJ; Magerfleisch L; Vanarsdalen KN; Tomaszewski JE; Wein AJ; Malkowicz SB; Guzzo TJ
    Urology; 2011 Mar; 77(3):548-52. PubMed ID: 21215436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment on: Improved accuracy in predicting the presence of gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy.
    Remzi M
    Eur Urol; 2007 Dec; 52(6):1668-9. PubMed ID: 17240039
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment. Long-term follow-up of men with isolated high-grade prostatic intra-epithelial neoplasia followed by serial delayed interval biopsy.
    Epstein JI
    Urology; 2011 Mar; 77(3):674-5; author reply 675-6. PubMed ID: 21377015
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of extended pattern technique for initial prostate biopsy.
    Siu W; Dunn RL; Shah RB; Wei JT
    J Urol; 2005 Aug; 174(2):505-9. PubMed ID: 16006881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment. Long-term follow-up of men with isolated high-grade prostatic intra-epithelial neoplasia followed by serial delayed interval biopsy.
    Jones JS
    Urology; 2011 Mar; 77(3):674; author reply 675-6. PubMed ID: 21377014
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeat prostate needle biopsy: who needs it?
    Ellis WJ; Brawer MK
    J Urol; 1995 May; 153(5):1496-8. PubMed ID: 7536254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comment. ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program.
    Bartoletti R; Cai T
    Urology; 2011 Mar; 77(3):e1; author reply e2. PubMed ID: 21376994
    [No Abstract]   [Full Text] [Related]  

  • 9. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
    Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
    BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.
    Cupp MR; Bostwick DG; Myers RP; Oesterling JE
    J Urol; 1995 May; 153(5):1543-8. PubMed ID: 7714976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment.
    Parsons JK
    J Urol; 2009 Oct; 182(4):1340-1; discussion 1341. PubMed ID: 19683271
    [No Abstract]   [Full Text] [Related]  

  • 12. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment.
    Matvey T; Polascik TJ
    Urology; 2011 May; 77(5):1152-3; author reply 1153-4. PubMed ID: 21539966
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment.
    Haas GP; Delongchamps NB
    Urology; 2011 May; 77(5):1153; author reply 1153-4. PubMed ID: 21539967
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transrectal prostatic biopsy using Franzen's needle in the cytologic diagnosis of prostatic cancer].
    Ventura M; Barasolo E; Morano E; Bollero E
    J Urol Nephrol (Paris); 1977; 83(10-11):858-62. PubMed ID: 599623
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of free prostate-specific antigen measurement in prostate-specific antigen screening for prostate cancer.
    Johnson L
    Clin Prostate Cancer; 2002 Dec; 1(3):142-4. PubMed ID: 15046688
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment on: Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?
    Stanislaus P; Seitz M
    Eur Urol; 2009 Apr; 55(4):909-10. PubMed ID: 18485577
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment on: Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy. what can they teach us?
    Scattoni V
    Eur Urol; 2009 Apr; 55(4):910. PubMed ID: 18485582
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving cancer detection by prostate biopsy: the role of core number and site.
    Shinohara K
    Nat Clin Pract Urol; 2006 Oct; 3(10):526-7. PubMed ID: 17031375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.